eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

SCImago Journal & Country Rank
 
6/2009
vol. 8
 
Share:
Share:
more
 
 
abstract:
Review paper

Cardiologic safety of menopausal hormone therapies

Grzegorz Stachowiak
,
Tomasz Pertyński

Przegląd Menopauzalny 2009; 6: 315-319
Online publish date: 2010/02/08
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Cardiovascular diseases appear to be the most frequent concomitant illnesses of the menopausal period. They are not only the main reasons of women’s deaths in the Western countries but also the most serious (but fortunately rare) complications of menopausal hormone therapies (MHT). In this article some cardiovascular risk factors influencing circulatory complications of MHT together with authors’ point of view concerning therapeutic safety were discussed. A particular attention has been paid to the choice of proper progestogen what plays a crucial role in the area of MHT safety.
keywords:

menopause, cardiovascular diseases, hormonal therapy, progestins

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.